Chicago, IL, United States of America

Bruce Tan


Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Baltimore, MD (US) (2012)
  • Chicago, IL (US) (2010 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Bruce Tan: Pioneering Advances in Lymphoma Research

Introduction:

Bruce Tan is a distinguished inventor hailing from Chicago, IL (US), known for his innovative contributions in the field of lymphoma research. With a total of 4 patents to his name, his groundbreaking work has significantly advanced the identification, diagnosis, and prediction of survival in lymphomas and lymphoproliferative disorders.

Latest Patents:

Tan's latest patents showcase his expertise in leveraging gene expression data to enhance the accuracy of identifying, diagnosing, and predicting survival of lymphomas. The development of the Lymph Dx microarray has proven instrumental in obtaining crucial gene expression data from lymphoma samples, ultimately aiding in tailoring specific therapeutic approaches for individual subjects.

Career Highlights:

Throughout his career, Tan has held key roles in prestigious organizations such as the University of Nebraska and The United States of America Department of Health and Human Services. His commitment to pushing the boundaries of innovation in healthcare has not gone unnoticed, with his patents standing as a testament to his dedication and expertise in the field.

Collaborations:

Tan has had the privilege of collaborating with esteemed professionals in the field, including notable coworkers such as George Wright and Louis M Staudt. These collaborations have undoubtedly enriched his research endeavors, fostering a creative environment conducive to pioneering advancements in lymphoma research.

Conclusion:

Inventor Bruce Tan's contributions to the field of lymphoma research have been nothing short of exceptional. His innovative methods for identifying, diagnosing, and predicting survival in lymphomas have laid the foundation for personalized therapeutic interventions, promising a brighter future for patients battling these complex disorders. Tan's relentless pursuit of excellence continues to inspire and shape the landscape of modern healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…